[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0301371D0 - New Compounds - Google Patents

New Compounds

Info

Publication number
SE0301371D0
SE0301371D0 SE0301371A SE0301371A SE0301371D0 SE 0301371 D0 SE0301371 D0 SE 0301371D0 SE 0301371 A SE0301371 A SE 0301371A SE 0301371 A SE0301371 A SE 0301371A SE 0301371 D0 SE0301371 D0 SE 0301371D0
Authority
SE
Sweden
Prior art keywords
hydrogen
halogen
new compounds
compounds
conr
Prior art date
Application number
SE0301371A
Other languages
English (en)
Inventor
Britt-Marie Swahn
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0301371A priority Critical patent/SE0301371D0/sv
Publication of SE0301371D0 publication Critical patent/SE0301371D0/sv
Priority to PCT/SE2004/000695 priority patent/WO2004099190A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0301371A 2003-05-09 2003-05-09 New Compounds SE0301371D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301371A SE0301371D0 (sv) 2003-05-09 2003-05-09 New Compounds
PCT/SE2004/000695 WO2004099190A1 (en) 2003-05-09 2004-05-06 Novel substituted benzimidazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301371A SE0301371D0 (sv) 2003-05-09 2003-05-09 New Compounds

Publications (1)

Publication Number Publication Date
SE0301371D0 true SE0301371D0 (sv) 2003-05-09

Family

ID=20291269

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301371A SE0301371D0 (sv) 2003-05-09 2003-05-09 New Compounds

Country Status (2)

Country Link
SE (1) SE0301371D0 (sv)
WO (1) WO2004099190A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1676574A3 (en) 2004-12-30 2006-07-26 Johnson & Johnson Vision Care, Inc. Methods for promoting survival of transplanted tissues and cells
WO2006078907A1 (en) 2005-01-20 2006-07-27 Amgen Inc. 2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments
RS51351B (en) 2005-07-20 2011-02-28 Aventis Pharma S.A. 1,4-DIHYDROPYRIDINE-CONDENSED HTEROCYCLES, PROCEDURES FOR THEIR PRODUCTION, USE AND THE COMPOSITIONS CONTAINING THEM
CA3000985C (en) 2014-10-14 2023-01-31 The Board Of Trustees Of The Leland Stanford Junior University Method for treating neurodegenerative diseases
KR20180094989A (ko) 2015-12-15 2018-08-24 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 주니어 유니버시티 노화 관련 인지장애 및 신경염증의 예방 및/또는 치료 방법
CN107141310A (zh) * 2016-08-08 2017-09-08 重庆文理学院 一种新型抗菌锌配合物的制备方法及其应用
MX2021001456A (es) 2018-08-06 2021-05-27 Univ Leland Stanford Junior 2-arilbenzimidazoles como activadores de ppargc1a para tratar enfermedades neurodegenerativas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63112584A (ja) * 1986-10-29 1988-05-17 Yoshitomi Pharmaceut Ind Ltd イミダゾピリジン誘導体
JPH07121937B2 (ja) * 1987-03-18 1995-12-25 大塚製薬株式会社 カルボスチリル誘導体
US20030008832A1 (en) * 1998-11-25 2003-01-09 Rifat Pamukcu Method of inhibiting neoplastic cells with benzimidazole derivatives
DE19920936A1 (de) * 1999-05-07 2000-11-09 Basf Ag Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto

Also Published As

Publication number Publication date
WO2004099190A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
ATE450533T1 (de) Carboxamidderivate
YU96103A (sh) Novi derivati indola sa afinitetom za 5-ht6 receptor
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
IS2376B (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
TNSN03110A1 (en) Azaindoles.
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
IS6520A (is) Ný efnasambönd
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
DE60305724D1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
TW200745111A (en) New compounds
NO20085077L (no) Nye forbindelser
MXPA04007414A (es) Indoles sustituidos como agonistas alfa-1.
NO20075169L (no) Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme.
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
ATE386725T1 (de) Heterocyclylverbindungen
SG171471A1 (en) New benzimidazole derivatives
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.
TW200800984A (en) New compounds
SE0102055D0 (sv) New Compounds
SE0102440D0 (sv) New compound
SE0401655D0 (sv) New compounds
SE0301371D0 (sv) New Compounds
ATE406363T1 (de) Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten